Sustained-release formulations like Glutathione-SR bypass digestive breakdown, ensuring better absorption and consistent cellular protection
The incidence varies between different products and doses, with constipation listed as 'very common' (affecting more than 1 in 10 people) with Wegovy and Saxenda, and 'common' (affecting up to 1 in 10 people) with Ozempic, Trulicity and Mounjaro
Elevated Blood Sugar Levels : Diminished GLP-1 activity can impair insulin secretion and glucose regulation, contributing to hyperglycemia and an increased risk of type 2 diabetes [28,29]
That is a 47% greater relative reduction not a marginal statistical difference, but a clinically meaningful one
This is why pharmacy-grade temperature control is non-negotiable for injectable GLP-1 therapy
How do we personalize treatments to fit individual needs